Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin before vestibuloplasty in edentulous mandibular patients
PACTR202607744838559Unknown
- Sponsor
- Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of neuronox in edentulism and mandibular alveolar ridge atrophy (2 arms), sponsored by Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University. Primary endpoint: Vestibular/sulcus depth relapse. Status: unknown.
02
Drugs
neuronox
03
Conditions
edentulismmandibular alveolar ridge atrophy
Beyond the preview
Go deeper on PACTR202607744838559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607744838559.